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Abbreviations 
3D-CT = three-dimensional computed tomographic 
COPD = chronic obstructive pulmonary disease 
SC = segment counting 
VC = vital capacity 
 FEV1 = forced expiratory volume in 1 second 
 DLco = diffusion capacity of the lung for carbon monoxide 
 HU = Hounsfield units 
LAA = low-attenuation area 
 FLV = functional lung volume 
 ppo- = predicted postoperative 
 post- = measured postoperative 
SD = standard deviation 
LOA = limits of agreement 
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Abstract 
Purpose: It is important to accurately predict the patient’s postoperative pulmonary function. The aim of this study was 
to compare the accuracy of predictions of the postoperative residual pulmonary function obtained with three-dimensional 
computed tomographic (3D-CT) volumetry with that of predictions obtained with the conventional segment-counting 
method.  
Methods: Fifty-three patients scheduled to undergo lung cancer resection, pulmonary function tests, and computed 
tomography were enrolled in this study. The postoperative residual pulmonary function was predicted based on the 
segment-counting and 3D-CT volumetry methods. The predicted postoperative values were compared with the results of 
postoperative pulmonary function tests. 
Results: Regarding the linear correlation coefficients between the predicted postoperative values and the measured 
values, those obtained using the 3D-CT volumetry method tended to be higher than those acquired using the 
segment-counting method. In addition, the variations between the predicted and measured values were smaller with the 
3D-CT volumetry method than with the segment-counting method. These results were more obvious in COPD patients 
than in non-COPD patients. 
Conclusions: My findings suggested that the 3D-CT volumetry was able to predict the residual pulmonary function 
more accurately than the segment-counting method, especially in patients with COPD. This method might lead to the 
selection of appropriate candidates for surgery among patients with a marginal pulmonary function.  
Keywords: three-dimensional computed tomographic volumetry, segment-counting method, residual pulmonary function, 
chronic obstructive pulmonary disease 
2 
 
Introduction 
Surgical resection remains the principal treatment for early stage lung cancer, although new chemotherapeutic agents and 
molecular-targeted drugs have been developed. However, surgical resection cannot be used to treat patients with a poor 
pulmonary function or complications such as chronic obstructive pulmonary disease (COPD) and interstitial pneumonitis 
[1,2]. In order to conduct pulmonary resection safely, it is necessary to ensure that the patient’s postoperative pulmonary 
function remains above acceptable levels [3].  
The prediction of the residual pulmonary function after lung resection has conventionally been performed using 
the segment-counting method [4,5]. However, the segment-counting method is based solely on the number of remaining 
pulmonary segments, and differences between the volumes of each segment are ignored. These issues are expected to 
interfere with the prediction of the postoperative residual pulmonary function. It was reported that three-dimensional 
computed tomographic (3D-CT) volumetry produces more accurate predictions of the postoperative residual pulmonary 
function than the segment-counting method [6-8], and its use for such purposes might help reduce the frequency of 
postoperative complications [9,10]. In particular, patients with a poor preoperative pulmonary function, such as those 
with COPD, suffer more postoperative problems than those with a normal pulmonary function [11,12].  
The purpose of the present study was to compare the accuracy of the postoperative residual pulmonary function 
predicted using 3D-CT volumetry with that predicted using the conventional segment-counting method in lung cancer 
patients, especially those with a poor pulmonary function. 
  
3 
 
Methods 
Patients 
The subjects of this study were 53 patients who underwent anatomical lung resection for primary lung cancer from April 
2012 to March 2014. All of the patients underwent a pulmonary function test and thin-slice computed tomography prior 
to surgery. Six months after surgery, they underwent a pulmonary function test again. The postoperative pulmonary 
functions predicted using the segment-counting and 3D-CT methods were compared among the same patients. Patient 
data, including the age, sex, smoking habits, tumor location, resection site, and pulmonary function test variables, were 
collected. The patients’ clinical characteristics are shown in Table 1. COPD was defined according to the Global Initiative 
on Obstructive Lung Disease Guidelines. Patients with COPD, who were those with forced expiratory volume in 1 
second percentage (FEV1%) values of <70%, accounted for 43.4% of the study population (23/53). All patients were 
informed about the research protocol and provided their written consent. This study was performed as a clinical trial and 
approved by the institutional review board of the Tsukuba University School of Medicine. The approval number was 
H24-66. 
 
CT examinations 
All preoperative CT examinations were performed using 64-row multi-slice helical CT (Brilliance 64; PHILIPS 
Electronics, Tokyo, Japan) and 256-row multi-slice helical CT (Brilliance iCT 256; PHILIPS Electronics) scanners. CT 
images 1-mm-thick covering the entire lung were obtained using the following parameters for the 64- and 256-row 
scanners with the patient in the supine position: deep inspiratory breath-holding; gantry rotation speed: 0.5 and 0.33 
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seconds, respectively; table speed: 41.2 and 183.8 mm/s, respectively; beam collimation: 64×0.625 and 128×0.625 mm, 
respectively; beam pitch: 0.515 and 0.758, respectively; peak tube voltage: 120 kv; tube current exposure time product: 
180-280 mAs; and pixel resolution: 512 × 512. Contrast medium was intravenously administered to delineate the 
boundaries between the tumor and mediastinal structures. A single-phase scan was obtained after 30 seconds of 
peripheral intravenous power injection of 100 mL of non-ionic iodine contrast medium (Iomeron 300; Bracco, Milano, 
Italia) at a rate of 1.6 to 3.0 mL/sec, depending on the size of the patient.  
 
Pulmonary function tests 
Pulmonary function tests, which assessed the vital capacity (VC), forced expiratory volume in 1 second (FEV1), FEV1%, 
and the diffusing capacity of the lung for carbon monoxide (DLco), were performed within one month prior to surgery 
and at six months after surgery with patients in the seated position. 
 
3D-CT volumetry and emphysema analyses 
All thin-slice CT data for each patient were transferred to a computer workstation (SYNAPSE VINCENT ver.3.0; 
FUJIFILM, Tokyo, Japan), on which 3D lung models were reconstructed. The 3D models could be viewed at multiple 
angles on the computer display, and the bronchial territory could be accurately extracted by designating the target 
segment or lobar bronchus. Furthermore, it was possible to calculate the volume of each extracted territory. The volumes 
of the trachea, bronchus, pulmonary artery, pulmonary vein, tumor, and other parenchymal structures, such as the tissues 
affected by atelectasis or organizing lesions, were calculated semi-automatically and selectively removed from the 3D 
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lung models. To evaluate the extent of emphysematous lung lesions, the proportion of the lung occupied by 
low-attenuation areas (LAA) was calculated by highlighting the areas with attenuation values of less than –910 
Hounsfield units (HU) [6,13-17]. The normal lung volume was calculated after excluding the emphysematous lung 
volume. In this study, LAA accounted for 13.44% of the lung tissue on average (Table 1). Finally, the volumes of the 
respiratory tract, blood vessels, tumor, and other parenchymal structures were excluded to determine the volume of the 
lung tissue that participates in breathing, which was called the functional lung volume (FLV) (Fig. 1) [6,13].  
 
Proportional volume of each segment 
Prior to the prediction of the residual pulmonary function, I examined whether or not there were marked variation in the 
proportional volume of each segment. All segmental bronchi were designated in all patients, and the volume of each 
segment was calculated using 3D-CT volumetry. The proportional volume of each segment relative to the volume of the 
whole lung was calculated. In the segment-counting method, because it is assumed that all segments except the left upper 
division are the same size, the proportional volume is calculated as follows: 1/19 ≒ 5.26%; and the proportional volume 
of the left upper division is calculated as follows: 1.5 / 19 ≒ 7.89%. In the 3D-CT volumetry method, the volume of each 
segment was calculated and compared with the volume of the same segment according to the segment-counting method. 
 
Segment-counting and 3D-CT volumetry methods 
The postoperative residual pulmonary function was predicted based on the segment-counting and 3D-CT volumetry 
methods using the formula and methods developed by Ali et al. and Gass GD et al., as described below [4,5]. 
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Predicted postoperative VC or FEV1 or DLco (ppo-VC, ppo-FEV1, ppo-DLco) = 
(1 – A / 19) × preoperative VC or FEV1 or DLco 
In the segment-counting method, A represents the total number of unobstructed segments in the resection lobe, 
which was assumed to be 3, 2, and 5 for the right upper, middle, and lower lobe, respectively, and 3, 2, and 4 for the left 
upper segment, lingular segment, and lower lobe, respectively, and 19 is the total number of segments in the whole lung. 
In the 3D-CT volumetry method, A represents the FLV of the resection portion of the lung, and the total number of 
segments is replaced by the total volume of the FLV of the whole lung. 
  The predicted postoperative values were compared with the postoperative measurements obtained at six 
months after the operation (post-VC, post-FEV1, post-DLco). 
 
Statistical analyses 
Data are reported as the mean ± standard deviation (SD) or median and range. The two-sample t-test, Kruskal-Wallis test, 
and Mann-Whitney U test were used to examine the relationships between categorical and numerical variables. The 
relationships between the measured and estimated numerical variables were determined using Pearson’s correlation 
coefficient and a linear regression analysis. The difference in the correlation coefficients was also assessed. Agreement 
between the predicted and measured numerical variables was analyzed by the Bland-Altman method to evaluate the 
variation. The limits of agreement were defined as the range of two standard deviations from the mean difference 
between the predicted and measured numerical variables. P-values of <0.05 were considered significant. PASW Statistics 
18 (SPSS, Chicago, IL, USA) was used for all analyses. 
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Results 
The patients’ clinical characteristics are shown in Table 1. The total number of patients in this study was 53. There were 
30 non-COPD patients (56.6%) and 23 COPD patients (43.4%). Compared with the non-COPD patients, the COPD 
patients were significantly older, included more smokers, and had lower FEV1, FEV1%, and DLco values. In addition, 
the postoperative FEV1, FEV1%, and DLco values of the COPD patients were significantly lower than those of the 
non-COPD patients. 
The proportional volume measurements obtained for each segment with the 3D-CT volumetry method differed 
significantly from those acquired with the segment-counting method, except in left segment 1+2 and segment 3 (p <0.01) 
(Fig. 2). The proportional volume measurements for right segments 1, 3, and 6 and left segment 1+2 and segment 3 were 
significantly larger than the values predicted using the segment-counting method. In contrast, the proportional volume 
measurements for right segments 7 and 9 and left segments 4, 5, 6, and 9 were significantly smaller than those predicted 
using the segment-counting method. The proportional volume measurements obtained for each lobe with the 3D-CT 
volumetry method were compared with those acquired with the segment-counting method in the same manner. The 
proportional volume measurement for the right upper lobe was significantly larger than that predicted using the 
segment-counting method. In addition, the proportional volume measurements for the right lower lobe, left upper lobe, 
and left lower lobe were significantly smaller than those predicted using the segment-counting method (Table 2). 
In the segment-counting method, the linear correlation coefficients for the relationships between ppo-VC and 
post-VC, ppo-FEV1 and post-FEV1, and ppo-DLco and post-DLco were 0.873 (p <0.01), 0.845 (p <0.01), and 0.826 (p 
<0.01), respectively. In the 3D-CT volumetry method, the linear correlation coefficients for the relationships between 
ppo-VC and post-VC, ppo-FEV1 and post-FEV1, and ppo-DLco and post-DLco were 0.885 (p <0.01), 0.884 (p <0.01), 
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and 0.843 (p <0.01), respectively (Table 3). There were no significant differences between the linear correlation 
coefficients of the two prediction methods, but all of the linear correlation coefficients obtained with the 3D-CT 
volumetry method tended to be higher than those acquired with the segment-counting method.  
In the segment-counting method, the limits of agreement between the predicted and postoperative measured 
values ranged from -0.66 to 0.66 in VC, from -0.63 to 0.37 in FEV1, and from -6.31 to 4.09 in DLco. In the 3D-CT 
volumetry method, the limits of agreement between the predicted and postoperative measured values ranged from -0.60 
to 0.64 in VC, from -0.55 to 0.33 in FEV1, and from -5.94 to 3.98 in DLco. The ranges of the limits of agreement 
obtained with the 3D-CT volumetry method were smaller than those acquired with the segment-counting method (Table 
4). 
The differences between the predictions obtained with the 3D-CT volumetry and segment-counting methods were 
analyzed separately in the COPD and non-COPD groups. In the non-COPD group, the linear correlation coefficients for 
the relationships between ppo-VC and post-VC, ppo-FEV1 and post-FEV1, and ppo-DLco and post-DLco were 0.927, 
0.877, and 0.905, respectively, when the segment-counting method was used (p <0.01), whereas they were 0.929, 0.916, 
and 0.912, respectively, when the 3D-CT volumetry method was used (p <0.01). In contrast, in the COPD group the 
linear correlation coefficients for the relationships between ppo-VC and post-VC, ppo-FEV1 and post-FEV1, and 
ppo-DLco and post-DLco were 0.740, 0.720, and 0.571, respectively, when the segment-counting method was used (p 
<0.01), whereas they were 0.785, 0.775, and 0.603, respectively, when the 3D-CT volumetry method was used (p <0.01) 
(Table 5). Although not to a significant degree, the differences between the linear correlation coefficients obtained with 
the two prediction methods tended to be larger in the COPD group than in the non-COPD group. 
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In the non-COPD group, the limits of agreement between the predicted and postoperative measured values ranged 
from -0.57 to 0.55 in VC, from -0.58 to 0.38 in FEV1, and from -5.90 to 2.50 in DLco when the segment-counting 
method was used, whereas they ranged from -0.57 to 0.55 in VC, from -0.48 to 0.32 in FEV1, and from -5.56 to 2.48 in 
DLco when the 3D-CT volumetry method was used. In contrast, in the COPD group, the limits of agreement between the 
predicted and postoperative measured values ranged from -0.74 to 0.78 in VC, from -0.70 to 0.34 in FEV1, and from 
-6.35 to 5.69 in DLco when the segment-counting method was used, whereas they were from -0.64 to 0.76 in VC, from 
-0.63 to 0.33 in FEV1, and from -5.99 to 5.49 in DLco when the 3D-CT volumetry method was used. The ranges of limits 
of agreement obtained with the 3D-CT volumetry method were smaller than those acquired with the segment-counting 
method in both the COPD group and non-COPD group. The differences between ranges of limits of agreement obtained 
with the two prediction methods were larger in the COPD group than in the non-COPD group, except for those of FEV1 
(Table 6). 
The linear correlation coefficients were examined to identify the relationship between the preoperative FEV1% and 
the proportion of LAA. In the COPD and non-COPD groups, the linear correlation coefficients for the relationship 
between the preoperative FEV1% and the proportion of LAA was 0.605 (p <0.01) and 0.112, respectively (p=0.557). A 
negative correlation between these variables was observed only in the COPD group. 
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Discussion 
In recent years, the number of lung cancer patients with poor risk factors for surgery, such as elderly age or coexisting 
diseases like COPD or restrictive pulmonary disease, has been increasing. Therefore, it is important to accurately predict 
patients’ postoperative residual pulmonary function in order to avoid postoperative respiratory function disorders. 
Originally, residual pulmonary function after lung resection had been predicted in the pneumonectomy. For this purpose, 
the bronchospirometric method, which tested pulmonary function by inserting an intrabronchial intubation tube into one 
side of the lungs, and the unilateral pulmonary artery occlusion test, which examined pulmonary and circulation change 
by occluding pulmonary artery, were used [18,19]. However, these methods are highly invasive and not able to cope with 
an operation less than lobectomy. Afterward, pulmonary ventilation and perfusion scintigraphy using radioisotopes were 
developed to check local pulmonary function less invasively [20,21]. These methods demonstrated relatively good 
correlation with the postoperative pulmonary function, but the radiation exposure to patients and technicians, and 
ventilation-perfusion imbalance due to gravity became problematic. Therefore, the segment-counting method, which 
predicts pulmonary function by calculating the number of segments to be resected, was devised. This simple method can 
predict the postoperative pulmonary function in a short time without performing any invasive examinations [4]. However, 
it was based solely on the number of remaining pulmonary segments, and did not take into account the heterogeneity of 
volume and function of every segment; therefore, it was unconvincing in terms of accuracy. To predict the postoperative 
pulmonary function more accurately, Wu et al. reported a quantitative CT method that predicts the postoperative 
pulmonary function by measuring the pulmonary volume on CT images [6]. The primitive quantitative CT method was a 
slice-by-slice method in which an observer manually delineates the outer perimeter of the lung on a large number of 
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thin-section CT images. Although this manual method was accurate, it was extremely time-consuming and impractical 
for routine clinical use. As there is not a large difference between the quantitative CT and segment-counting methods for 
lobectomy, the segment-counting method has been used for postoperative pulmonary function prediction [22]. From the 
above mentioned process, 3D-CT volumetry using image software was developed to predict the postoperative pulmonary 
function more simply and accurately. In the present study, I demonstrated that the relative volume of each segment 
differed significantly, as shown in Fig. 2. Therefore, predictions obtained using the segment-counting method may differ 
from the actual postoperative values. Furthermore, the relative volumes of each segment differed between the 3D-CT 
volumetry and segment-counting methods. Iwano et al. reported that 3D-CT volumetry using the Synapse Vincent 
volume analyzer was able to measure lobar volumes more precisely than the segment-counting-method [23]. Therefore, 
the volume of the lung to be resected can be predicted more precisely with 3D-CT volumetry than with the 
segment-counting method. In the present study, it was demonstrated that the relative volume of each segment differed 
significantly, as shown in Fig. 2. Therefore, predictions obtained using the segment-counting method might differ from 
the actual postoperative values. Furthermore, the relative volumes of each segment differed between the 3D-CT 
volumetry and segment-counting methods. Iwano et al. reported that 3D-CT volumetry using the Synapse Vincent 
volume analyzer was able to measure lobar volumes more precisely than the segment-counting-method [23]. Therefore, 
the volume of the resection lung could be predicted more precisely with 3D-CT volumetry than with the 
segment-counting method.  
The function of each pulmonary segment can vary between individuals and can also be affected by diseases, such 
as emphysema and fibrosis. The image analysis software program used in this study is able to calculate and exclude the 
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volume of blood vessels and tumors as well as atelectasis or organizing lesions. Furthermore, it can exclude 
emphysematous lesions by excluding low-attenuation areas. The postoperative residual pulmonary function is therefore 
believed to be predicted more accurately using the FLV, which excludes such non-functioning lung volumes, than using 
the segment-counting method [6,14,15,24]. Since the volume and function of each segment differ by individual, the 
values predicted with the 3D-CT volumetry method are expected to be well correlated with the postoperative pulmonary 
function.  
Although there is some software for pulmonary volumetry analysis, SYNAPSE VINCENT was used in this study 
for the following two points: First, the separation of pulmonary artery and vein, and each organ was possible by 
performing CT only in the venous phase, not in 2 arteriovenous phases. This was able to control organ shift due to 
breathing and reduce exposure to the patients [25]. In addition, accurate visualization of the pulmonary vein is important 
to revise errors in separation of pulmonary segments, which was an advantage over other software [26]. Second, 
automatic separation of the pulmonary lobe was possible with analysis of LAA and the %LAA of each pulmonary lobe 
was easily calculated in a short time [27]. Other software was only able to calculate the %LAA of total lung tissue or 
right and left lung separately, but not %LAA of each pulmonary lobe. This was useful to evaluate the function of each 
pulmonary lobe. 
In the present study, the values predicted with the 3D-CT volumetry method tended to be more closely correlated 
with the actual postoperative measurements than the predicted values obtained with the segment-counting method. In 
addition, according to the differences between the ranges of limits of agreement by method, the variations between the 
predicted and actual measured values were smaller with the 3D-CT volumetry method than with segment-counting 
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method. However, the difference between the correlation coefficients obtained with the two prediction methods was not 
very large among non-COPD patients, with the difference between the correlation coefficients obtained with the two 
prediction methods tending to be larger in the COPD group than in the non-COPD group. Furthermore, the ranges of the 
limits of agreement obtained with the 3D-CT volumetry method were smaller than those acquired with the 
segment-counting method in both the COPD and non-COPD groups.  
The differences in the variations of values obtained with the two prediction methods were smaller in the COPD 
group than in the non-COPD group, except for FEV1%. This suggests that the 3D-CT volumetry method is able to predict 
the postoperative residual pulmonary function more accurately in COPD patients than in non-COPD patients. The 
proportion of the lungs occupied by LAA was 16.59 ± 14.83 and 11.02 ± 7.74 in the COPD and non-COPD groups, 
respectively, a non-significant difference. However, a negative correlation between the preoperative FEV1% and the 
proportion of the lungs occupied by LAA was detected among the COPD patients but not the non-COPD patients. The 
3D-CT volumetry method may be able to detect non-functioning lung tissue (i.e. LAA), which can negatively influence 
the FEV1%, enabling this method to precisely evaluate the FLV by excluding such non-functioning lung tissue, especially 
in cases of COPD. Accordingly, the precise evaluation of the FLV with the 3D-CT method seems to result in more 
accurate predictions of the postoperative pulmonary function than the segment-counting method, especially in COPD 
patients. 
The main limitation of my study was that I did not consider the effects of lung volume reduction surgery. Lung 
volume reduction surgery removes emphysematous lesions and improves the lung function, possibly by increasing the 
airway conductance and the ratio of conductance to lung volume [28,29]. Therefore, in patients with severe COPD, both 
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a reduction in the amount of functioning lung tissue and an improvement in the function of the residual lung have to be 
considered, and these factors will be taken into account in my future studies. 
In conclusion, the segment volume can vary between segments and individuals; therefore, predictions of the 
residual pulmonary function obtained with the segment-counting method may be inaccurate. My findings suggest that the 
3D-CT-volumetry method is able to predict the residual pulmonary function more accurately than the segment-counting 
method, as the actual volume loss can be calculated, which may facilitate the selection of appropriate candidates for lung 
cancer surgery and reduce the risk of surgical complications, especially in patients with a relatively poor pulmonary 
function, such as those with COPD. 
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Table 1. Patients’ clinical characteristics 
Variables  Total (n=53) 
Non-COPD 
(FEV1% ≥70%) (n=30) 
COPD 
 (FEV1.0% <70%) (n=23) 
P-value 
Non COPD vs. COPD 
Age (years) 66 ± 11 (38-86) 63 ± 12 (38-79)  71 ± 8 (54-86) 0.01 
Sex (male/female) 31/22 15/15 16/7 0.096 
Pack-years smoked 36 ± 35 (0-116) 24 ± 32 (0-116) 51 ± 32 (0-108) 0.004 
VC (l) 3.34 ± 0.78 (1.99-5.70) 3.31 ± 0.88 (1.99-5.70) 3.37 ± 0.65 (2.01-4.33) 0.781 
FEV1 (l) 2.30 ± 0.56 (1.15-4.10) 2.48 ± 0.58 (1.46-4.10) 2.07 ± 0.46 (1.15-2.86) 0.008 
FEV1% (%) 70.93 ± 9.34(46.60-91.10) 77.18 ± 5.61(70.00-91.11) 62.78 ± 6.47(46.60-69.80) <0.001 
DLco (ml/min/mmHg) 15.51 ± 4.94 (7.36-28.94) 16.75 ± 5.32 (7.36-28.94) 13.80 ± 3.67 (8.22-21.01) 0.03 
Proportion of LAA (%) 13.44 ± 11.58 (0-56.90) 11.02 ± 7.74 (0-26.40) 16.59 ± 14.83 (0-56.90) 0.112 
Resection site  
   
0.224 
Right upper lobe 13 7 6   
Right middle lobe 2 1 1   
Right lower lobe 11 6 5   
Left upper lobe 12 7 5   
Left lower lobe 10 6 4   
Others 5 3 2   
Postoperative VC (l) 2.62 ± 0.66 (1.55-4.41) 2.63 ± 0.73 (1.55-4.41) 2.61 ± 0.56 (1.74-4.10) 0.929 
Postoperative FEV1 (l) 1.93 ± 0.44 (1.12-3.06) 2.03 ± 0.47 (1.34-3.06) 1.79 ± 0.37 (1.12-2.38) 0.043 
Postoperative FEV1% (%) 74.89 ± 10.16 (52.30-93.50) 79.35 ± 7.77 (67.40-93.50) 69.07± 10.10 (52.30-89.90) <0.001 
Postoperative  
DLco (ml/min/mmHg) 
13.27 ± 4.61 (4.95-25.00) 14.80 ± 4.89 (4.95-25.00) 11.29 ± 3.39 (5.07-22.18) 0.005 
Data are expressed as the mean ± standard deviation (range). VC: vital capacity, FEV1: forced expiratory volume in 1 second, FEV1%: forced expiratory volume in 1 
second percentage. DLco: diffusing capacity of the lung for carbon monoxide, COPD: chronic obstructive pulmonary disease, LAA: low-attenuation areas
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Table 2. Proportional volumes of various segments and lobes according to the 3D-CT and 
segment-counting methods 
Data are expressed as the median (range). 3D-CT: three-dimensional computed tomography. 
Segment/lobe 
Proportional volume  
according to the 3D-CT method (%) 
Proportional volume 
according to the SC method (%) 
P-value 
Rt. segment 1 6.70 (1.50 - 13.40) 5.26 0.007 
Rt. segment 2 5.60 (2.10 - 12.00) 5.26 0.107 
Rt. segment 3 9.10 (5.20 - 13.40) 5.26 <0.001 
Rt. segment 4 5.00 (0.90 - 7.20) 5.26 0.107 
Rt. segment 5 5.30 (1.60 - 10.40) 5.26 0.858 
Rt. segment 6 5.70 (2.50 - 10.20) 5.26 0.049 
Rt. segment 7 2.30 (0.60 - 5.50) 5.26 <0.001 
Rt. segment 8 5.20 (1.40 - 9.20) 5.26 0.858 
Rt. segment 9 3.70 (0.90 - 8.00) 5.26 <0.001 
Rt. segment 10 4.90 (2.00 - 10.50) 5.26 0.21 
Lt. segment 1+2 9.10 (4.70 - 18.00) 7.89 <0.001 
Lt. segment 3 8.40 (4.90 - 17.60) 7.89 0.049 
Lt. segment 4 4.00 (1.40 - 7.70) 5.26 <0.001 
Lt. segment 5 3.00 (1.00 - 8.80) 5.26 <0.001 
Lt. segment 6 4.50 (2.00 - 8.40) 5.26 <0.001 
Lt. segment 8 5.40 (2.40 - 8.90) 5.26 0.107 
Lt. segment 9 4.00 (1.70 - 7.70) 5.26 <0.001 
Lt. segment 10 5.20 (2.40 - 10.00) 5.26 0.858 
Right upper lobe 21.90 (10.60 - 36.50) 15.79 <0.001 
Right middle lobe 10.30 (3.90 - 16.10) 10.53 0.21 
Right lower lobe 22.90 (9.20 - 32.60) 26.32 <0.001 
Left upper lobe 26.00 (17.50 - 39.10) 26.32 0.02 
Left lower lobe 19.70 (12.30 - 14.60) 21.05 0.01 
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Table 3. The linear correlations between the predicted postoperative pulmonary function and the 
measured postoperative pulmonary function  
Variables Coefficient P-value 
ppo-VC, SC vs. post-VC 0.873 <0.01 
ppo-VC,
 CT vs. post-VC 0.885 <0.01 
ppo-FEV1, SC vs. post-FEV1 0.845 <0.01 
ppo-FEV1, CT vs. post-FEV1 0.884 <0.01 
ppo-DLco, SC vs. post-DLco 0.826 <0.01 
ppo-DLco, CT vs. post-DLco 0.843 <0.01 
ppo-VC: predicted postoperative vital capacity, ppo-VC, SC: ppo-VC predicted using the 
segment-counting method, ppo-VC, CT: ppo-VC predicted using 3D-CT volumetry, post-VC: measured 
postoperative VC, ppo-FEV1: predicted postoperative forced expiratory volume in 1 second, ppo-FEV1, 
SC: ppo-FEV1 predicted using the segment-counting method, ppo-FEV1, CT: ppo-FEV1 predicted using 
3D-CT volumetry, post-FEV1: measured postoperative FEV1, ppo-DLco: predicted postoperative 
diffusing capacity of the lung for carbon monoxide, ppo-DLco, SC: ppo-DLco predicted using the 
segment-counting method, ppo-DLco, CT: ppo-DLco predicted using 3D-CT volumetry, post-DLco: 
measured postoperative DLco  
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Table 4. An analysis of the limits of agreement between the predicted postoperative pulmonary function 
and the measured postoperative pulmonary function 
Variables Difference LOA 
ppo-VC, SC vs post-VC 0.00 ± 0.33 -0.66 to 0.66 
ppo-VC, CT vs post-VC 0.02 ± 0.31 -0.60 to 0.64 
ppo-FEV1, SC vs post-FEV1 -0.13 ± 0.25 -0.63 to 0.37 
ppo-FEV1, CT vs post-FEV1 -0.11 ± 0.22 -0.55 to 0.33 
ppo-DLco, SC vs post-Dlco -1.11 ± 2.60 -6.31 to 4.09 
ppo-DLco, CT vs post-Dlco -0.98 ± 2.48 -5.94 to 3.98 
The difference between the predicted and measured values is expressed as the mean ± standard deviation. 
The limits of agreement (LOA) is expressed as a range of standard deviations from the mean difference. 
ppo-VC: predicted postoperative vital capacity, ppo-VC, SC: ppo-VC predicted using the 
segment-counting method, ppo-VC, CT: ppo-VC predicted using 3D-CT volumetry, post-VC: measured 
postoperative VC, ppo-FEV1: predicted postoperative forced expiratory volume in 1 second, ppo-FEV1, 
SC: ppo-FEV1 predicted using the segment-counting method, ppo-FEV1, CT: ppo-FEV1 predicted using 
3D-CT volumetry, post-FEV1: measured postoperative FEV1, ppo-DLco: predicted postoperative 
diffusing capacity of the lung for carbon monoxide, ppo-DLco, SC: ppo-DLco predicted using the 
segment-counting method, ppo-DLco, CT: ppo-DLco predicted using 3D-CT volumetry, post-DLco: 
measured postoperative DLco 
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Table 5. The linear correlations between the predicted postoperative pulmonary function and the 
measured postoperative pulmonary function in the COPD and non-COPD groups 
 
Non-COPD group (n=30)  COPD group (n=23) 
Variables Coefficient P-value  Coefficient P-value 
ppo-VC, SC vs. post-VC 0.927 <0.01  0.740 <0.01 
ppo-VC,
 CT vs. post-VC 0.929 <0.01  0.785 <0.01 
ppo-FEV1, SC vs. post-FEV1 0.877 <0.01  0.720 <0.01 
ppo-FEV1, CT vs. post-FEV1 0.916 <0.01  0.775 <0.01 
ppo-DLco, SC vs. post-DLco 0.905 <0.01  0.571 <0.01 
ppo-DLco, CT vs. post-DLco 0.912 <0.01  0.603 <0.01 
ppo-VC: predicted postoperative vital capacity, ppo-VC, SC: ppo-VC predicted using the 
segment-counting method, ppo-VC, CT: ppo-VC predicted using 3D-CT volumetry, post-VC: measured 
postoperative VC, ppo-FEV1: predicted postoperative forced expiratory volume in 1 second, ppo-FEV1, 
SC: ppo-FEV1 predicted using the segment-counting method, ppo-FEV1, CT: ppo-FEV1 predicted using 
3D-CT volumetry, post-FEV1: measured postoperative FEV1, ppo-DLco: predicted postoperative 
diffusing capacity of the lung for carbon monoxide, ppo-DLco, SC: ppo-DLco predicted using the 
segment-counting method, ppo-DLco, CT: ppo-DLco predicted using 3D-CT volumetry, post-DLco: 
measured postoperative DLco
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Table 6. An analysis of the limits of agreement between the predicted postoperative pulmonary function 
and the measured postoperative pulmonary function in the COPD and non-COPD groups 
 
Non-COPD group (n=30)  COPD group (n=23) 
Variables difference LOA  difference LOA 
ppo-VC, SC vs post-VC -0.01 ± 0.28 -0.57 to 0.55  0.02 ± 0.38 -0.74 to 0.78 
ppo-VC, CT vs post-VC -0.01 ± 0.28 -0.57 to 0.55  -0.06 ± 0.35 -0.64 to 0.76 
ppo-FEV1, SC vs post-FEV1 -0.10 ± 0.24 -0.58 to 0.38  -0.18 ± 0.26 -0.70 to 0.34 
ppo-FEV1, CT vs post-FEV1 -0.08 ± 0.20 -0.48 to 0.32  -0.15 ± 0.24 -0.63 to 0.33 
ppo-DLco, SC vs post-Dlco -1.70 ± 2.10 -5.90 to 2.50  -0.33 ± 3.01 -6.35 to 5.69 
ppo-DLco, CT vs post-Dlco -1.54 ± 2.01 -5.56 to 2.48  -0.25 ± 2.87 -5.99 to 5.49 
The difference between the predicted and measured values is expressed as the mean ± standard deviation. 
The limits of agreement (LOA) is expressed as a range of standard deviations from the mean difference. 
ppo-VC: predicted postoperative vital capacity, ppo-VC, SC: ppo-VC predicted using the 
segment-counting method, ppo-VC, CT: ppo-VC predicted using 3D-CT volumetry, post-VC: measured 
postoperative VC, ppo-FEV1: predicted postoperative forced expiratory volume in 1 second, ppo-FEV1, 
SC: ppo-FEV1 predicted using the segment-counting method, ppo-FEV1, CT: ppo-FEV1 predicted using 
3D-CT volumetry, post-FEV1: measured postoperative FEV1, ppo-DLco: predicted postoperative 
diffusing capacity of the lung for carbon monoxide, ppo-DLco, SC: ppo-DLco predicted using the 
segment-counting method, ppo-DLco, CT: ppo-DLco predicted using 3D-CT volumetry, post-DLco: 
measured postoperative DLco
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Fig. 1. The bronchial territories were extracted from three-dimensional lung models by specifying the 
target segment or lobe, and the volume of each territory was calculated concurrently. The volumes of the 
respiratory tract, blood vessels, tumors, and other parenchymal structures, such as tissue affected by 
atelectasis or organizing lesions, were calculated semi-automatically or selectively. The proportion of the 
lungs occupied by low-attenuation areas was calculated by highlighting the areas with attenuation values 
of less than –910 HU. The total lung volume, except for the volume of the lung tissue that does not 
participate in breathing, was described as the functional lung volume. 
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Fig. 2. The proportional volume of each segment is shown as a box and whisker plot. The central line 
indicates 1/19 ×100 = 5.26%, which is the volume ratio of 1 segment according to the segment-counting 
method. Significant differences were determined using the Kruskal–Wallis test (p <0.01). RU = right 
upper lobe, RM = right middle lobe, RL = right lower lobe, LU = left upper lobe, LL = left lower lobe. 
 
